New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2012
09:18 EDTBBBY, RAD, VVUS, NYX, FOLD, CAG, ORCL, MDRX, DFS, JBL, ELOQ, ICEOn The Fly: Pre-market Movers
HIGHER AFTER EARNINGS: Rite Aid (RAD), up 17.3%... Jabil Circuit (JBL), up 5.4%... ConAgra (CAG), up 3.1%... ALSO HIGHER: NYSE Euronext (NYX), up 40.2% after acquisition by IntercontinentalExchange (ICE) for $33.12 per share in case and stock... Eloqua (ELOQ), up 30% after agreeing to be bought by Oracle (ORCL) for $23.50... VIVUS (VVUS), up 7.9% after Express Scripts (ESRX) adds Qsymia to formulary, takeover speculation fueled by Daily Mail report... LOWER AFTER EARNINGS: Bed Bath & Beyond (BBBY), down 5.8%... Discover (DFS), down 2.2%... ALSO LOWER: Amicus Therapeutics (FOLD), down 43.5% after drug doesn't show statistical benefit in study... Allscripts (MDRX), down 15.9% after evaluation of strategic alternatives ends without sale, CEO steps down.
News For NYX;ICE;MDRX;VVUS;ELOQ;ORCL;RAD;JBL;CAG;BBBY;DFS;FOLD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 29, 2015
11:09 EDTFOLD, BBBYOptions with increasing implied volatility
Subscribe for More Information
10:19 EDTMDRXAllscripts management to meet with Jefferies
Subscribe for More Information
10:01 EDTFOLDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:07 EDTFOLDAmicus initiated with a Buy at Chardan
Subscribe for More Information
06:12 EDTICENYSE planning midday auction for thinly traded shares, WSJ reports
Subscribe for More Information
May 28, 2015
11:17 EDTORCLBofA/Merrill software analyst holds an analyst/industry conference call
Subscribe for More Information
11:15 EDTBBBYOptions with increasing implied volatility
Subscribe for More Information
05:53 EDTORCLObama administration urges justices not to hear Google-Oracle case, WSJ says
Subscribe for More Information
May 27, 2015
14:47 EDTORCLAnalysts debate Workday after post-earnings selloff
Last night's results and guidance from Workday (WDAY) prompted a selloff in the stock a several cautious notes from research firms. However, multiple analysts remain bullish on the company and see strong prospects hidden behind the "relatively conservative" guidance. WHAT'S NEW: After the market close on Tuesday, Workday reported first quarter losses per share of (2c) on revenues of $251M, both of which beat consensus estimates. However, the company's second quarter revenue guidance of $270M-$274M bracketed the consensus forecast of about $272M. ANALYST REACTIONS: Brean Capital's Sarah Hindlian noted that traders were likely disappointed by the lack of major client announcements for Workday's FMS product, but said she believes FMS will be successful in the long term. Hindlian added that she expects Workday to become a "clear winner" eventually, but warned of a significant correction in the stock and noted that "significant" R&D spending is required before the company can capture the full market and she reiterates a Hold rating on the stock. Jefferies' John DiFucci and Brad Zelnick were less hopeful, saying the company's 31% billings growth versus 69% last year reflects "very aggressive" competition from Oracle (ORCL) and SAP (SAP), which could signal lessened momentum for Workday. The firm believes renewals may be a bright spot for the company going forward, but kept a Hold rating on the stock and cut its price target to $92 from $99 on the shares. Wells Fargo's Jason Maynard said the company's "relatively conservative" guidance is likely due to some lag in large deal signings as well as a relatively slow acceleration in Europe. The firm lowered its price target to $105-$110 from $110-$120, but remained optimistic on Workday, citing "extremely strong" renewals, new client wins in human capital management, and a maturing financial product. Richard Davis and David Hynes from Canaccord lowered Workday's price target to $100 from $110, but nevertheless said they believe the company faces a "decade of growth." The firm was not surprised at the recent selloff and recommended using weakness in the stock price to fill out investment positions in Workday. PRICE ACTION: Workday is down over 10% to about $83 per share in afternoon trading. Oracle and SAP are up roughly 1.8% and 1%, respectively.
10:36 EDTBBBYOptions with increasing implied volatility
Options with increasing implied volatility: QUNR DGX FOSL BBBY ACN NKE EFA EMR
10:01 EDTRADOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abbott (ABT) initiated with a Buy at Evercore ISI... Aldeyra (ALDX) initiated with a Buy at Janney Capital... Black Stone Minerals (BSM) initiated with a Neutral at Credit Suisse... Boston Scientific (BSX) initiated with a Buy at Evercore ISI... Cidara Therapeutics (CDTX) initiated with a Buy at BTIG... Coach (COH) initiated with an Underweight at BB&T... Diplomat Pharmacy (DPLO) initiated with an Outperform at Raymond James... EPIRUS (EPRS) initiated with a Buy at BTIG... Enviva (EVA) initiated with a Buy at Citigroup... General Finance Corp (GFN) initiated with an Outperform at Oppenheimer... Hortonworks (HDP) initiated with an Outperform at Oppenheimer... Jarden (JAH) initiated with a Buy at UBS... Kate Spade (KATE) initiated with a Buy at BB&T... Medtronic (MDT) initiated with a Hold at Evercore ISI... MoneyGram (MGI) initiated with a Neutral at Goldman... Opexa Therapeutics (OPXA) initiated with a Buy at Maxim... Paratek Pharmaceuticals (PRTK) initiated with a Buy at BTIG... Progenics (PGNX) initiated with a Buy at BTIG... Rite Aid (RAD) initiated with a Buy at Mizuho... St. Jude Medical (STJ) initiated with a Buy at Evercore ISI... Starwood Waypoint (SWAY) initiated with an Outperform at Wells Fargo... Talen Energy (TLN) initiated with a Hold at Deutsche Bank... Ulta Salon (ULTA) initiated with a Buy at Buckingham... Vipshop (VIPS) initiated with a Buy at Stifel... Virtu Financial (VIRT) initiated with a Neutral at Citigroup... Vista Outdoor (VSTO) initiated with a Buy at Wunderlich... ZELTIQ (ZLTQ) initiated with a Buy at Northcoast... eBay (EBAY) initiated with a Buy at Topeka.
06:27 EDTORCLUS administration backs Oracle in Google case, Financial Times reports
Subscribe for More Information
05:36 EDTRADRite Aid initiated with a Buy at Mizuho
Subscribe for More Information
05:20 EDTORCLJefferies cuts Workday price target on moderating growth
Subscribe for More Information
May 26, 2015
11:54 EDTBBBYOptions with increasing implied volatility
Options with increasing implied volatility: VIPS DGX CVC JIVE LBTYA BBBY YHOO NKE CAN DTV
08:08 EDTMDRXAllscripts signs agreement to deploy its PAS in the U.K.
Subscribe for More Information
07:06 EDTFOLDAmicus granted Accelerated Assessment by EMA
Amicus Therapeutics announced that the Committee for Medicinal Products for Human Use, or CHMP. of the European Medicines Agency, or EMA, has granted Accelerated Assessment to the oral small molecule pharmacological chaperone migalastat HCl monotherapy for Fabry patients who have amenable genetic mutations. Migalastat is the first investigational Fabry drug to be granted Accelerated Assessment.
06:38 EDTORCLMicrosoft buying Salesforce 'makes a lot of sense,' says Piper Jaffray
Subscribe for More Information
May 22, 2015
11:08 EDTRADStocks with call strike movement; RAD AAL
Rite Aid (RAD) October 10 call option implied volatility decreased 5% to 40, American Airlines (AAL) November 50 call option implied volatility increased 4% to 37 according to IVolatility.
May 21, 2015
08:15 EDTORCLSalesforce acquisition still possible, says JMP Securities
After Salesforce reported stronger than expected results, JMP Securities indicated that the results, along with statements by the company's CEO, make an acquisition seem less likely. However, the firm continues to believe that Google (GOOG), Oracle (ORCL), or Microsoft (MSFT) could buy the company. All three potential acquirers have significant cash and strong potential synergies with Salesforce, and the world is moving to the cloud, the firm explained. It raised its price target on Salesforce to $80 from $75 and keeps an Outperform rating on the shares.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use